Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug [Yahoo! Finance]
Gelteq Limited - Ordinary Shares (GELS)
Company Research
Source: Yahoo! Finance
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and biotechnology company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, sports, and other products, announces today that the U.S. Food and Drug Administration (“FDA”) has approved its suitability petition for a new animal drug under development. The new animal drug leverages Gelteq's ingestible gel platform designed for nutrient and drug delivery. A suitability petition is a request by a drug sponsor to submit an abbreviated new animal drug application (“ANADA”) for a proposed innovative new animal drug that differs from a previously FDA approved generic animal drug. “We believe there is enormous opportunity for us in the animal pharmaceuticals market, as there is a significant need to deliver medications more efficiently,” Gelteq co-founder and CEO Nathan Givoni said. “This pathway,
Show less
Read more
Impact Snapshot
Event Time:
GELS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GELS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GELS alerts
High impacting Gelteq Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
GELS
News
- Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology [Yahoo! Finance]Yahoo! Finance
- Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel TechnologyGlobeNewswire
- Gelteq Receives FDA Approval of its Suitability Petition for New Animal DrugGlobeNewswire
- Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor ConferenceGlobeNewswire
- Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand [Yahoo! Finance]Yahoo! Finance
GELS
Sec Filings
- 11/15/24 - Form 20-F
- 10/31/24 - Form NT
- 10/30/24 - Form 6-K
- GELS's page on the SEC website